[Congressional Record Volume 171, Number 71 (Tuesday, April 29, 2025)]
[House]
[Page H1688]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
RECOGNIZING DAVID SPARKS FOR CONTRIBUTIONS TO PHARMACEUTICAL INDUSTRY
(Mr. Carter of Georgia was recognized to address the House for 5
minutes.)
Mr. CARTER of Georgia. Mr. Speaker, I rise today to recognize David
Sparks for his outstanding contributions and visionary leadership in
the pharmaceutical industry.
As the previous CEO and current chairman of the board at the
Professional Compounding Centers of America, PCCA, Mr. Sparks has been
instrumental in advancing the pharmaceutical industry. Since joining
PCCA in 1992, he has fought to protect pharmacists' rights to compound,
playing a key role in FDA reform legislation. Before PCCA, he owned
pharmacies in Tulsa for over two decades, pioneering the introduction
of compounding pharmacies in hospice care.
Committed to education, Mr. Sparks is a proud contributor to the
SWOSU general scholarship fund, ensuring that future pharmacists have
the essential resources to succeed. He is also an adjunct professor at
the University of Houston College of Pharmacy and an active member of
its Mading Society of benefactors. He remains a dedicated advocate for
the advancement of pharmacy, continuously supporting the profession
through leadership and philanthropy.
Mr. Sparks' impact on the pharmaceutical industry is profound and
lasting, and his leadership will continue to shape its future.
Recognizing Jim Smith for Leadership in Pharmaceutical Compounding
Mr. CARTER of Georgia. Mr. Speaker, I rise today to recognize Jim
Smith, a distinguished leader whose dedication and vision have
profoundly impacted both the Professional Compounding Centers of
America, PCCA, and the healthcare industry.
His educational background, including a bachelor of science in
chemistry and biology from West Texas A&M University and an MBA from
the University of Portland, has shaped his strategic leadership.
Since joining PCCA in 2000, Mr. Smith has played a crucial role in
the organization's growth, serving as president, chief operating
officer, vice president of sales and marketing, and a key member of the
strategic management team. His leadership has strengthened PCCA's core
capabilities, driving innovation and excellence in pharmaceutical
compounding.
Prior to his tenure, Mr. Smith leveraged his expertise in home
health, specialty medicine, respiratory pharmacy, long-term care
pharmacy, and compounding support, demonstrating his commitment to
advancing patient care.
Today, as executive adviser to the PCCA board of directors, Mr. Smith
continues to shape the industry, ensuring that innovation and patient
care remain at the forefront.
Mr. Smith's dedication exemplifies the highest standards of
leadership and service.
Congratulating Gus Bassani, a Visionary in Pharmaceutical Compounding
Mr. CARTER of Georgia. Mr. Speaker, I rise today to congratulate Gus
Bassani, a longtime leader and visionary in the pharmacy compounding
industry who has recently assumed the role of chief executive officer
of the Professional Compounding Centers of America, PCCA.
Mr. Bassani earned his doctor of pharmacy degree from Drake
University's College of Pharmacy and Health Sciences. Since then, he
has been invaluable in various settings within the pharmaceutical
industry.
Mr. Bassani embraces opportunities to give back, teaching
extemporaneous compounding principles to pharmacy students at Drake
University.
Mr. Bassani has been with PCCA since September 2002, actively
participating in legislative, regulatory, and public affairs
initiatives. At PCCA, he has been a visionary, contributing extensively
to the organization's scientific, technical, and strategic pursuits.
In addition to his outstanding work with PCCA, Mr. Bassani has
previously served on the United States Pharmacopeia Compounding Expert
Committee.
Mr. Speaker, I congratulate Mr. Bassani on this exciting achievement,
and I wish him the best in his new role.
____________________